Synmosa Biopharma (4114) — Financial Flexibility Index
Synmosa Biopharma (4114) has a Financial Flexibility Index of 0.06x as of December 2025. Free cash flow of NT$245.19 Million (operating CF NT$185.72 Million minus capex NT$59.46 Million) represents 0% of total liabilities (NT$3.89 Billion). Check Synmosa Biopharma (4114) strategic investment index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Synmosa Biopharma Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Synmosa Biopharma across 11 annual periods. See how liquid is Synmosa Biopharma's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Synmosa Biopharma (2015–2025)
Year-by-year free cash flow to debt coverage for Synmosa Biopharma. For the full company profile including market capitalisation, see market value of Synmosa Biopharma.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.18x | NT$692.71 Million | NT$411.57 Million | NT$3.89 Billion | ▼ -33.7% |
| 2024 | 0.27x | NT$1.05 Billion | NT$780.62 Million | NT$3.91 Billion | ▲ +24.8% |
| 2023 | 0.22x | NT$781.70 Million | NT$511.93 Million | NT$3.63 Billion | ▲ +29.2% |
| 2022 | 0.17x | NT$759.54 Million | NT$630.25 Million | NT$4.55 Billion | ▲ +31.0% |
| 2021 | 0.13x | NT$537.35 Million | NT$444.29 Million | NT$4.22 Billion | ▲ +37.7% |
| 2020 | 0.09x | NT$408.81 Million | NT$254.40 Million | NT$4.42 Billion | ▲ +161.4% |
| 2019 | 0.04x | NT$138.49 Million | NT$-44.88 Million | NT$3.92 Billion | ▼ -67.3% |
| 2018 | 0.11x | NT$330.43 Million | NT$16.00 Million | NT$3.06 Billion | ▲ +169.6% |
| 2017 | 0.04x | NT$141.74 Million | NT$-5.19 Million | NT$3.54 Billion | ▼ -85.2% |
| 2016 | 0.27x | NT$660.40 Million | NT$236.48 Million | NT$2.44 Billion | ▲ +8.9% |
| 2015 | 0.25x | NT$392.86 Million | NT$23.60 Million | NT$1.58 Billion | — |